Aviva cancer pledge takes in Avastin and more
by Gill Montia
Story link: Aviva cancer pledge takes in Avastin and more
Aviva will soon be providing enhanced cover for cancer treatment, following the removal of benefit limits for some drugs.
In its new cancer “pledge” the insurer says treatments recommended by medical specialists will be covered in full, including targeted therapies such as Herceptin and Avastin, and unlicensed drugs not readily available from the NHS.
Aviva will also fund in full bisphosphonates (drugs to keep bones strong during cancer treatment) and stem cell and bone marrow transplants.
New benefits will also help support customers through their cancer treatment as follows:
Cover for specialist nursing care and rehabilitation support.
Cover for anti-sickness drugs and drugs to help combat the side effects of cancer treatments.
Up to £100 towards the cost of a wig.
Benefit towards internal and external prostheses.
Routine check-ups for up to 10 years following cancer treatment.
Where end of life care is required, Aviva will donate up to £10,000 to the hospice or charity and provide care at home if needed.
Aviva UK Health’s head of clinical development, Dr Doug Wright, comments: “We understand the emotional and physical challenges that customers face when they undergo cancer treatment and want to do everything we can to make living with cancer that bit easier.”
He adds: “Our customers told us that they want the peace of mind that we’ll pay for their cancer treatment in full for as long as their specialist says they need it – so that’s what we’re giving them through our cancer pledge.”
The new cover will apply to customers taking out a private medical insurance policy, or renewing, from 1st January 2012.
Customers taking out a company scheme covering 250 or more employees have the option to decrease the cover available, if they wish.